在T细胞淋巴瘤中,由eIF4E和XPO1调节GATA-3依赖的转录组和瘤微环境
Nermin Kady1,2, Suhaib Abdelrahman1, Ahmar M Rauf1
1Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
Blood
|December 9, 2024
概括
核出口蛋白XPO1在T细胞淋巴瘤 (TCL) 和它们的微观环境中高度表达. 用selinexor准XPO1显示出治疗这些具有挑战性的癌症的前景.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 在T细胞淋巴瘤 (TCLs) 中,GATA结合蛋白3 (GATA-3) 驱动瘤发生.
- 许多TCL是耐化学药的,并且失去像TP53和PTEN这样的瘤抑制剂,这些抑制剂与核出口蛋白XPO1.1有关.
- 在瘤微环境 (TME) 内的恶性T细胞和淋巴瘤相关巨细胞 (LAMs) 中,XPO1被上调.
研究的目的:
- 研究XPO1在TCL中的作用,特别是在TP53-和PTEN缺乏的环境中.
- 探索TP53-和PTEN独立的机制,涉及TCL中的eIF4E和XPO1.
- 评估选择性XPO1抗剂塞利尼克索尔作为TCL的治疗剂.
主要方法:
- 利用基因工程TCLs的小鼠模型.
- 在TCL中使用互补和正交的方法来研究eIF4E和XPO1.
- 评估了TME内的恶性T细胞和LAM中XPO1的表达.
主要成果:
- 缺乏TP53和/或PTEN的TCL及其相关的LAM对selinexor敏感.
- 确定了eIF4E/XPO1在GATA-3及其在TCL中的依赖转录的核出口中的新角色.
- 证明了XPO1在从LAM中导出治疗相关的转录中的作用,例如殖民地刺激因子-1受体.
结论:
- XPO1对抗性会损害TCL中的瘤转录程序.
- 在XPO1对抗作用下,LAMs从TME中耗尽.
- 针对XPO1提供了一种新的策略,以解决难以治疗的TCL中的两个独立依赖关系.
更多相关视频
相关概念视频
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
General Transcription Factors
5.2K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.2K


